Esophageal Tumors

Slide 1 · Esophageal Tumors

Major histologic types • Barrett-associated adenocarcinoma • clinical significance

A source-grounded pathology lecture

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning outcomes

Classify major esophageal neoplasms by histologic lineage

Relate Barrett metaplasia and dysplasia to adenocarcinoma

Recognize essential gross and microscopic features

Connect invasion, symptoms and survival to disease extent

Slide 3 · The major tumor families

Esophageal neoplasms

Epithelial: Adenocarcinoma / SCC

Mesenchymal: Leiomyoma

Other rare malignancies

Nearly all esophageal cancers are adenocarcinoma or squamous cell carcinoma

Slide 4 · Histologic lineage matters

Adenocarcinoma

Squamous cell carcinoma

Adenocarcinoma is gland-forming, often mucin-producing

Squamous cell carcinoma recapitulates squamous differentiation

A tumor’s location and precursor lesion help support its origin

Slide 5 · A worldwide histologic shift

Squamous cell carcinoma remains more common globally

Adenocarcinoma has risen markedly in the United States and other Western countries

Different risk patterns underlie the geographic contrast

SCC worldwide

EAC rising in West

Slide 6 · Leiomyoma: The leading benign tumor

Intramural mesenchymal nodule

Schematic esophageal wall

Most benign esophageal tumors are mesenchymal

Slide 7 · Uncommon malignant lineages

Unusual forms of adenocarcinoma and undifferentiated carcinoma

Neuroendocrine carcinoma and melanoma

Lymphoma and sarcoma

Robbins mentions these but does not detail them in this section

Slide 8 · Anatomic location is informative

Upper

Middle

Distal

Distal adenocarcinoma

Schematic; Tumor locations vary

Adenocarcinoma preferentially affects the distal third

Slide 9 · Symptoms often reflect advanced disease

Surface epithelium

Lamina propria

Muscularis mucosae

Submucosa • lymphatics

Muscularis propria

Illustrative path of increasing depth

Difficulty or pain on swallowing may appear late

Slide 10 · Adenocarcinoma commonly follows Barrett esophagus

Chronic reflux

Barrett metaplasia

Epithelial dysplasia

Adenocarcinoma

Schematic sequence — conceptual progression, not an inevitable patient course

Long-standing gastroesophageal reflux disease is a key background

Slide 11 · Why reflux increases cancer risk

Reduced reflux barrier

Chronic GERD

Barrett mucosa

Increased EAC risk

Schematic sequence — conceptual progression, not an inevitable patient course

The textbook links increased adenocarcinoma rates to GERD and Barrett esophagus

Slide 12 · Barrett mucosa: Endoscopic appearance

Salmon-red metaplastic mucosa

Original schematic, not endoscopic evidence

Tongues of red, velvety mucosa extend above the gastroesophageal junction

Slide 13 · The squamous–columnar transition

Stratified squamous epithelium

Intestinalized columnar epithelium

Schematic — not a photomicrograph

Normal esophagus is lined by stratified squamous epithelium

Slide 14 · Goblet cells identify intestinal metaplasia

Stratified squamous epithelium

Intestinalized columnar epithelium

Schematic — not a photomicrograph

Goblet cells contain conspicuous mucin vacuoles

Slide 15 · Short- and long-segment Barrett esophagus

Short segment <3 cm

Long segment ≥3 cm

Conceptual comparison; Not drawn to scale

Long-segment disease extends ≥3 cm above the junction

Slide 16 · Cancer risk is not inevitable

Associated precursor

Not inevitable cancer

Most esophageal adenocarcinomas arise with Barrett esophagus

Most people with Barrett esophagus never develop esophageal tumors

Metaplasia must not be equated with carcinoma

Slide 17 · Dysplasia is a preinvasive change

Metaplasia

Low-grade dysplasia

High-grade dysplasia

Invasive carcinoma

Schematic sequence — conceptual progression, not an inevitable patient course

Barrett dysplasia arises in metaplastic epithelium

Slide 18 · Shared cytologic features of dysplasia

Schematic — crowded atypical nuclei extend toward the surface

Nuclear hyperchromasia and atypical mitotic activity

Slide 19 · Dysplastic glands lose regular architecture

Schematic — crowding and irregular gland outlines

Irregular gland shapes and budding

Slide 20 · Low-grade dysplasia: Characteristic pattern

Schematic — elongated, stratified nuclei within columnar glands

Elongated, stratified hyperchromatic nuclei

Slide 21 · High-grade dysplasia: Greater disorder

Schematic — severe gland crowding and cribriform complexity

More severe cytologic and architectural abnormalities

Slide 22 · When is carcinoma invasive?

Surface epithelium

Lamina propria

Muscularis mucosae

Submucosa • lymphatics

Muscularis propria

Illustrative path of increasing depth

Dysplasia remains intraepithelial

Slide 23 · Dysplasia and surveillance

Endoscopy

Targeted/systematic biopsy

Histologic grade

Risk assessment

Schematic sequence — conceptual progression, not an inevitable patient course

Barrett esophagus is identified by endoscopy with biopsy

Slide 24 · Endoscopic treatment is stage-dependent

The text discusses radiofrequency ablation and endoscopic mucosal resection for dysplasia

Selected superficial carcinoma may also be treated endoscopically

Management depends on extent, comorbidity and specialist assessment

Endoscopy

Biopsy

Ablation / resection

Slide 25 · The dominant risk pathway

Obesity / LES dysfunction

GERD

Barrett esophagus

Adenocarcinoma risk

Schematic sequence — conceptual progression, not an inevitable patient course

Chronic GERD and Barrett esophagus are central to adenocarcinoma risk

Slide 26 · Additional exposure associations

Tobacco use

Dietary nitrosamines

Radiation exposure

Tobacco use

Slide 27 · Dietary patterns linked to lower risk

Fresh fruits and vegetables

Whole grains and dietary fiber

Vitamins C and B6, and folate

Fresh fruits and vegetables

Slide 28 · Helicobacter pylori: Inverse association

Some H. Pylori strains

Gastric atrophy

Lower acid output

Less reflux injury

Schematic sequence — conceptual progression, not an inevitable patient course

Some H. Pylori serotypes correlate with lower adenocarcinoma risk

Slide 29 · Alcohol distinguishes carcinoma subtypes

Adenocarcinoma: Alcohol not a risk association

Squamous carcinoma: Alcohol + tobacco synergy

Alcohol is not associated with increased adenocarcinoma risk

Alcohol and tobacco synergize in squamous cell carcinoma

Risk-factor patterns must not be transferred from one histotype to the other

Slide 30 · Sex and ancestral distribution

7×

Male predominance reported

Figures are reported; Not a current population estimate

Adenocarcinoma about seven-fold more common in males

Slide 31 · Marked geographic heterogeneity

Higher

Lower

United States; United Kingdom

Korea; Thailand

Canada; Australia

Japan; Ecuador

Netherlands; Brazil

—

Slide 32 · Adenocarcinoma incidence rose in the West

<5% → >60%

U.S. Proportion of esophageal cancers; Historical comparison

Figures are reported; Not a current population estimate

The text describes a pronounced increase since 1970

Slide 33 · Risk factors should be synthesized

Risk environment

Barrett metaplasia

Molecular alterations

Tumor progression

Schematic sequence — conceptual progression, not an inevitable patient course

Exposure: Reflux, tobacco, radiation, dietary associations

Slide 34 · Neoplastic progression accumulates alterations

Metaplastic field

Early suppressor defects

Further alterations

Invasive adenocarcinoma

Schematic sequence — conceptual progression, not an inevitable patient course

A stepwise genetic and epigenetic process

Slide 35 · Chromosomal instability is characteristic

Chromosomal instability

TP53

CDKN2A

Adenocarcinomas often show multiple chromosomal abnormalities

Slide 36 · TP53: Early tumor-suppressor alteration

TP53

Early change

Tumor-suppressor pathway

TP53 abnormalities can be detected early in neoplastic evolution

Slide 37 · CDKN2A products restrain neoplasia

CDKN2A

P16 / ARF

Early inactivation

CDKN2A is another early-affected suppressor locus

Slide 38 · Genetic loss and epigenetic silencing

Allelic loss

Promoter hypermethylation

Allelic loss removes functional tumor-suppressor material

Hypermethylation can silence expression without changing sequence

Both mechanisms are described at CDKN2A in the source

Slide 39 · Oncogene amplification can accompany progression

ERBB2 • EGFR

VEGFA • KRAS

CCND1 • CDK6

ERBB2, VEGFA and EGFR

Slide 40 · No single obligatory molecular sequence

Barrett mucosa

Variable early alterations

Variable amplifications

Malignant phenotype

Schematic sequence — conceptual progression, not an inevitable patient course

Chromosomal instability can yield heterogeneous combinations of changes

Slide 41 · Distal esophagus is the typical site

Upper

Middle

Distal

Distal adenocarcinoma

Schematic; Tumor locations vary

Adenocarcinoma usually develops in the distal one-third

Slide 42 · Early gross lesions may be subtle

Small flat or raised mucosal change

Conceptual gross morphology schematic

Initial lesions may appear as flat mucosal patches

Slide 43 · Advanced gross growth patterns

Luminal encroachment / wall infiltration

Conceptual gross morphology schematic

Some tumors form large, protruding masses

Slide 44 · Esophagogastric junction: An origin problem

Upper

Middle

Distal

Distal adenocarcinoma

Schematic; Tumor locations vary

Advanced distal esophageal tumors may be indistinguishable from gastric cardia primaries

Slide 45 · Gland formation identifies conventional adenocarcinoma

Schematic — variably sized atypical glands with lumens

Typical tumors show irregular malignant glands

Slide 46 · Tumor mucin is a characteristic product

Schematic — blue luminal material represents tumor mucin

Most conventional tumors are mucin-producing

Slide 47 · Intestinal-type morphology predominates

Schematic — variably sized atypical glands with lumens

Typical adenocarcinoma has intestinal-type gland formation

Slide 48 · Signet-ring cells are a less common pattern

Schematic signet-ring cells: Mucin vacuole displaces nucleus

Some tumors infiltrate diffusely as signet-ring cells

Slide 49 · Poorly differentiated patterns also occur

Conventional glands

Poorly differentiated cells

Rare tumors consist of small poorly differentiated cells

The text compares this appearance to small cell carcinoma of lung

Atypical morphology requires careful classification

Slide 50 · Residual Barrett mucosa helps localize origin

Stratified squamous epithelium

Intestinalized columnar epithelium

Schematic — not a photomicrograph

Barrett metaplasia often borders an esophageal adenocarcinoma

Slide 51 · Dysplasia and invasive glands: Conceptual contrast

Surface epithelium

Lamina propria

Muscularis mucosae

Submucosa • lymphatics

Muscularis propria

Illustrative path of increasing depth

Dysplasia: Abnormal epithelium remains confined to epithelial compartments

Slide 52 · Superficial versus advanced invasion

Surface epithelium

Lamina propria

Muscularis mucosae

Submucosa • lymphatics

Muscularis propria

Illustrative path of increasing depth

Carcinoma restricted to mucosa or submucosa has a substantially better reported outcome

Slide 53 · Early lesions may be found incidentally

GERD/Barrett evaluation

Endoscopy

Biopsy

Earlier diagnosis

Schematic sequence — conceptual progression, not an inevitable patient course

Evaluation for GERD may identify unsuspected neoplasia

Slide 54 · Progressive dysphagia reflects narrowing

Luminal encroachment / wall infiltration

Conceptual gross morphology schematic

Tumor growth and infiltrative wall thickening impair bolus transit

Slide 55 · Weight loss is multifactorial

Tumor mass

Swallowing difficulty

Reduced intake

Weight loss

Schematic sequence — conceptual progression, not an inevitable patient course

Impaired swallowing reduces effective oral intake

Slide 56 · Bleeding and chest symptoms

Hematemesis can accompany tumor ulceration

Chest pain or vomiting may occur

These symptoms are nonspecific; Tissue diagnosis is necessary

Dysphagia

Weight loss

Bleeding

Chest symptoms

Slide 57 · Submucosal lymphatics explain early spread

Surface epithelium

Lamina propria

Muscularis mucosae

Submucosa • lymphatics

Muscularis propria

Illustrative path of increasing depth

By symptomatic presentation, tumor frequently reaches submucosal lymphatics

Slide 58 · Extent at diagnosis strongly changes survival

~80% vs <25%

Five-year survival: Superficial vs commonly symptomatic EAC (Robbins)

Figures are reported; Not a current population estimate

Typical 5-year survival <25% for symptomatic adenocarcinoma

Slide 59 · A different pathway: Squamous carcinoma

Barrett → adenocarcinoma

Squamous dysplasia → SCC

Squamous carcinoma typically begins as squamous dysplasia

It is most common in the proximal and middle esophagus

Alcohol, tobacco and other injury exposures are major associations

Slide 60 · Squamous carcinoma: Key morphology

Schematic — epithelial nests and central keratinization

Gray-white plaques can precede a larger tumor

Slide 61 · Adenocarcinoma versus squamous carcinoma

Feature

Adenocarcinoma

Squamous cell carcinoma

Typical site

Distal third

Middle / proximal

Precursor

Barrett dysplasia

Squamous dysplasia

Morphology

Malignant glands; Mucin

Malignant squamous nests

Association

GERD; Barrett

Alcohol; Tobacco

Slide 62 · Case: Barrett surveillance biopsy

A patient with long-standing reflux has Barrett epithelium on biopsy

Glands show stratified hyperchromatic nuclei but no stromal infiltration

Interpretation: Dysplasia, not automatically invasive adenocarcinoma

Teaching vignette — hypothetical scenario consistent with source findings

Slide 63 · Case: A distal obstructing tumor

Progressive dysphagia and weight loss accompany a distal esophageal mass

Biopsy shows atypical, infiltrative mucin-producing glands

Most consistent major histotype: Adenocarcinoma

Teaching vignette — hypothetical scenario consistent with source findings

Slide 64 · Pattern recognition: Glands versus nests

Malignant glands

Squamous nests

Irregular glandular lumens favor adenocarcinoma

Squamous nests with differentiation favor squamous cell carcinoma

Correlate histology with mucosal precursor and anatomic site

Slide 65 · Five clinicopathologic conclusions

Adenocarcinoma and squamous carcinoma dominate esophageal cancer

Barrett dysplasia is the principal precursor of adenocarcinoma

Chromosomal instability accompanies neoplastic evolution

Distal location and malignant mucin-producing glands favor adenocarcinoma

Early depth-limited disease has a much better reported prognosis

Slide 66 · Diagnostic integration at sign-out

Determine the site: distal esophagus, esophagogastric junction or other level

Identify lineage: malignant gland formation versus squamous differentiation

Assess adjacent precursor tissue: Barrett metaplasia or squamous dysplasia

Describe invasion depth and potential lymphatic access